SlideShare a Scribd company logo
A Basic Understanding of HIV SurveillanceReferenceSOURCEUNAIDS/WHO Dr Rajeev Kashyap B.Sc., B.D.S ., M.Sc. (DPH)U.K C.C.R.A., P.M.I., C.R.A.A(Canada)
Impact of the HIV/AIDS worldwide epidemic  Every day, over 6,800 persons become infected with HIV.  Every day, over 5,700 persons die from AIDS, mostly because of lack of access to HIV prevention and treatment services.                                           (Source: UNAIDS/WHO 2007)
Prevalence of the Epidemic
Biology: The Virus  Since AIDS was first recognized in 1981, extensive research has shown that HIV is the virus that causes AIDS.  HIV is a retrovirus, a family of viruses that carry their genetic information on a single strand of RNA.  HIV infects a number of different cells in the body. Most important are two classes of white blood cells that are involved with protecting the body against infection: ,[object Object]
Macrophages As the number of these cells is depleted because of the virus, patients become immunodeficient, meaning their immune systems are insufficient to ward off infections. They develop opportunistic infections and certain cancers.
Biology: HIV Types
How HIV Is Transmitted Both HIV-1 and HIV-2 are transmitted in the same ways:  The predominant route of transmission is through Unprotected heterosexual intercourse      or       Homosexual intercourse between men.  HIV is also transmitted through blood, blood products, and donated organs (also referred to as parenteral transmission).   HIV may be transmitted from an infected mother to her fetus or infant during pregnancy, delivery or when breastfeeding (also referred to as perinatal transmission).
Transmission: Increased Risk A number of factors increase the risk of becoming infected with HIV through sexual intercourse.  These fall into two broad categories: ,[object Object]
Transmission-related factors : factors include the viral load of the infected patient, type of intercourse, the coexistence of sexually transmitted infections (STIs), and failure to use prevention methods such as condoms.,[object Object]
Some STIs such as chlamydia are more easily acquired by adolescent women, making young women more susceptible,[object Object]
Factors that Affect HIV/AIDS Prevalence  High prevalence of sexually transmitted infections (STIs)   Limited access to STI management  Limited access to, or social non-acceptance of, condoms  War and civil disturbance  Cultural/ethnic practices  Women’s low status  Low literacy rates  Increasing urbanization, migration, and mobilization  Low level of political commitment  Exposure to blood from unsafe medical practices and/or traditional practices
The two main factors driving the HIV/AIDS epidemic in Asia are injection drug use and commercial sex.
[object Object],[object Object]
Prevention of Mother-To-Child Transmission A short-course antiretroviral regimen given to the mother and the newborn baby can substantially reduce the risk of perinatal transmission of HIV during pregnancy and childbirth.
HIV-Positive Mothers     HIV-positive mothers can avoid the risk of transmission through infected breast milk by using breast milk substitutes. However, significant health risks are associated with this practice: Malnutrition  Exposure to other infections     For this reason, WHO/UNICEF/UNAIDS have developed several documents that address HIV and breastfeeding.
Antiretroviral Drugs Treatment
Antiretroviral drugs are used to treat HIV infection. In the past, the high cost of these drugs made them rarely used in most developing countries. Several agencies are now making funds available for antiretroviral and other therapies. These organizations includeThe Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Bank Multi-sectoral AIDS Plan (MAP) and The United States President’s Emergency Plan for AIDS Relief (PEPFAR).
ARV Therapy    ARV therapy has reduced the rate of progressing to AIDS in areas where these drugs are accessible. It has also been associated with changes in the types of opportunistic infections that appear with AIDS.
Classes of antiretroviral drugs There are three classes of antiretroviral drugs:  Nucleoside reverse transcriptase inhibitors (NRTIs)  Non-nucleoside reverse transcriptase inhibitors (nNRTIs)  Protease inhibitors (Pis)
WHO recommends the following antiretroviral therapy strategy First line drugs: 2 NRTI + 1 NNRTI  Second line drugs: 2 NRTI + PI   Surveillance is an important tool to monitor drug resistance in populations on treatment.
Preventing & Treating Opportunistic Infections  In addition to antiretroviral drugs, the treatment of HIV infection includes diagnosis, prophylaxis, andtreatment of selected opportunistic infections.  Anti-tuberculosis (TB) drugs extend the lives of patients with both HIV and TB.  Cotrimoxazoleprophylaxis has been used successfully to prevent the onset of opportunistic infections in HIV-positive patients in sub-Saharan Africa.  Vaccines are available for some potential opportunistic infections, such as pneumococcal disease
Main Components of Public Health Surveillance The main components of surveillance include: The systematic collection, analysis, and evaluation of morbidity and mortality reports and other relevant data Timely and regular distribution of information about the trends and patterns of disease to those who need to know Use of the information for disease prevention and control measures   An important part of the definition is that surveillance systems involve ongoing collection and use of health data
SomeProblems -disease surveillance systems  Duplication of effort Delay in reporting Inadequate data collection, analysis, use and dissemination  Lack of integrated training  Lack of evaluation Lack of laboratory involvement and coordination Lack of supervision
The cycle begins when cases of disease occur. It is complete when information about these cases is made available  and used for prevention and control of the disease.  The analyzed and interpreted data must be communicated to the people and agencies that need to use them. An information loop or cycle that involves:  ,[object Object]
Public health agencies
The public,[object Object]
Sentinel surveillance
Laboratory-based reporting
Case definition
Prevalence
Incidence
Passive surveillance
Active surveillance,[object Object]
Relationship between Disease and Case Definition
Relationship between disease and case definition is described in definitions below Sensitivity - The ability of a case definition or laboratory test to predict true disease (a/(a+c)). Specificity - The ability of a case definition or laboratory test to predict absence of true disease (d/(b+d)). Positive predictive value - The proportion of persons meeting a case definition, having a positive laboratory test that have true disease (a/(a+b)). Negative predictive value - The proportion of persons not meeting a case definition, having a negative laboratory test that do not have true disease (d/(c+d)).
Purpose of HIV/AIDS Surveillance       Epidemiologic surveillance is to detect trends in disease incidence and prevalenceover time Providing an accurate assessment of the distribution of disease by person, place and time  Providing information on changes or trends in disease distribution by geographic, socio-demographic or exposure parameters Identifying groups or geographical areas for targeted intervention efforts Providing information to evaluate effectiveness of intervention efforts Providing data for prevention program management (such as for voluntary counselling and testing, prevention of mother-to-child transmission and sexually transmitted infection management) Providing data for development and implementation of research efforts
Prevalence and Incidence Prevalence measures the level of HIV infection in a population. It is measured as a unitless proportion, such as the percent infected or the number of infections per thousand persons tested. Prevalence is influenced by both the rate of new infections (incidence) and the rate that infected people leave the population by death, cure or migration.  Incidence is the rate at which new HIV infections occur in a population in a given period of time. Because it is a rate, its unit of measurement always has time in the denominator
Core Elements  HIV case reporting involves routinely reporting all cases of HIV infection to accurately monitor the HIV epidemic, assess how the epidemic is changing, and create programs for HIV prevention and medical care that best serve affected people and communities.  AIDS case reporting involves routine reporting of specific data elements for persons diagnosed with AIDS in all or selected health facilities in the country to monitor AIDS morbidity in the general population.  HIV sero-surveillance seeks to estimate the prevalence of HIV infection in selected populations such as antenatal clinic (ANC) attendees, STI patients and blood donors by conducting sero-prevalence surveys in these populations on an ongoing basis.
Advantages and Disadvantages
Summary( Recap) The purpose of HIV/AIDS surveillance is to provide an accurate picture of the epidemic, which will then help to guide prevention and treatment programs. It helps to identify population sub-groups that are at higher risk for infection. Also, more information is provided on the distribution of disease over time and space. Now think of what the situation is like in your country. What is the approximate HIV prevalence in your district or province? Which sub-populations are most affected by the HIV/AIDS epidemic in your region?
The HIV/AIDS epidemic is becoming larger and more complex. Surveillance efforts must become more sophisticated if they are to be effective.
Today, we use second-generation HIV surveillance, which is designed to collect and integrate data reported from a variety of other sources:Behavioural surveillanceHIV/AIDS case reportingDeath registrationSexually transmitted infection (STI) surveillanceAdditional data provide a more comprehensive understanding of trends in the epidemic as well as the effectiveness of control and prevention measures.
Today, we use second-generation HIV surveillance, which is designed to collect and integrate data reported from a variety of other sources:Behavioural surveillanceHIV/AIDS case reportingDeath registrationSexually transmitted infection (STI) surveillanceAdditional data provide a more comprehensive understanding of trends in the epidemic as well as the effectiveness of control and prevention measures.
Goals The goals of second-generation HIV surveillance are: Better understanding of trends over time Better understanding of the behaviours driving the epidemic in a country Increased focus on sub-populations at highest risk for infection Flexibility to change with the state of the epidemic

More Related Content

What's hot

NACP Basics
NACP BasicsNACP Basics
NACP Basics
Spurthi Magdum
 
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptxMY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
AmruthaNambiar8
 
NTEP (National Tuberculosis Elimination Programme).pptx
NTEP (National Tuberculosis Elimination Programme).pptxNTEP (National Tuberculosis Elimination Programme).pptx
NTEP (National Tuberculosis Elimination Programme).pptx
Immanuel Joshua
 
Inter sectoral coordination
Inter sectoral coordinationInter sectoral coordination
Inter sectoral coordination
pramod kumar
 
NVBDCP
NVBDCPNVBDCP
National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)
Vivek Varat
 
National Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeNational Vector Borne Disease Control Programme
National Vector Borne Disease Control Programme
Dr Lipilekha Patnaik
 
The final ihr
The final ihrThe final ihr
The final ihr
kavita yadav
 
Disease Control Focused Health Program in Nepal
Disease Control Focused Health Program in NepalDisease Control Focused Health Program in Nepal
Disease Control Focused Health Program in Nepal
Mohammad Aslam Shaiekh
 
National framework for malaria elimination in india
National framework for malaria elimination in indiaNational framework for malaria elimination in india
National framework for malaria elimination in india
Aparna Chaudhary
 
Outbreak investigation steps
Outbreak investigation stepsOutbreak investigation steps
Outbreak investigation steps
Abdiwali Abdullahi Abdiwali
 
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
Vivek Varat
 
Surveillance
SurveillanceSurveillance
Surveillance
Janvi Chaubey
 
SAMPLE REGISTRATION SYSTEM (SRS) INDIA
SAMPLE REGISTRATION SYSTEM (SRS) INDIA SAMPLE REGISTRATION SYSTEM (SRS) INDIA
SAMPLE REGISTRATION SYSTEM (SRS) INDIA
Kirtti Kumar Bebarta
 
Public health emergencies
Public health emergenciesPublic health emergencies
Public health emergencies
Dr Bushra Jabeen
 
RNTCP
RNTCPRNTCP
First referral unit
First referral unitFirst referral unit
First referral unit
Thomaskutty Saji
 
Rashtriya bal swasthya karyakram (rbsk)
Rashtriya bal swasthya karyakram (rbsk)Rashtriya bal swasthya karyakram (rbsk)
Rashtriya bal swasthya karyakram (rbsk)
Sharon Treesa Antony
 
Iphs for subcentre
Iphs for subcentreIphs for subcentre
Iphs for subcentre
Deepak Upadhyay
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
Dr Lipilekha Patnaik
 

What's hot (20)

NACP Basics
NACP BasicsNACP Basics
NACP Basics
 
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptxMY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
MY PPT - NATIONAL FAMILY HEALTH SURVEY- 5 AND COMPERATIVES.pptx
 
NTEP (National Tuberculosis Elimination Programme).pptx
NTEP (National Tuberculosis Elimination Programme).pptxNTEP (National Tuberculosis Elimination Programme).pptx
NTEP (National Tuberculosis Elimination Programme).pptx
 
Inter sectoral coordination
Inter sectoral coordinationInter sectoral coordination
Inter sectoral coordination
 
NVBDCP
NVBDCPNVBDCP
NVBDCP
 
National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)
 
National Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeNational Vector Borne Disease Control Programme
National Vector Borne Disease Control Programme
 
The final ihr
The final ihrThe final ihr
The final ihr
 
Disease Control Focused Health Program in Nepal
Disease Control Focused Health Program in NepalDisease Control Focused Health Program in Nepal
Disease Control Focused Health Program in Nepal
 
National framework for malaria elimination in india
National framework for malaria elimination in indiaNational framework for malaria elimination in india
National framework for malaria elimination in india
 
Outbreak investigation steps
Outbreak investigation stepsOutbreak investigation steps
Outbreak investigation steps
 
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME (RNTCP)
 
Surveillance
SurveillanceSurveillance
Surveillance
 
SAMPLE REGISTRATION SYSTEM (SRS) INDIA
SAMPLE REGISTRATION SYSTEM (SRS) INDIA SAMPLE REGISTRATION SYSTEM (SRS) INDIA
SAMPLE REGISTRATION SYSTEM (SRS) INDIA
 
Public health emergencies
Public health emergenciesPublic health emergencies
Public health emergencies
 
RNTCP
RNTCPRNTCP
RNTCP
 
First referral unit
First referral unitFirst referral unit
First referral unit
 
Rashtriya bal swasthya karyakram (rbsk)
Rashtriya bal swasthya karyakram (rbsk)Rashtriya bal swasthya karyakram (rbsk)
Rashtriya bal swasthya karyakram (rbsk)
 
Iphs for subcentre
Iphs for subcentreIphs for subcentre
Iphs for subcentre
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
 

Viewers also liked

HIV/AIDS Among Persons Aged 50 years and Older
HIV/AIDS Among Persons Aged 50 years and OlderHIV/AIDS Among Persons Aged 50 years and Older
HIV/AIDS Among Persons Aged 50 years and Older
Dr. Karen Whiteman
 
Outline of the Philadelphia Prevention Plan
Outline of the Philadelphia Prevention PlanOutline of the Philadelphia Prevention Plan
Outline of the Philadelphia Prevention Plan
Office of HIV Planning
 
64686664 the-hiv-aids-epidemic-in-asia-jintanat-ananworanich
64686664 the-hiv-aids-epidemic-in-asia-jintanat-ananworanich64686664 the-hiv-aids-epidemic-in-asia-jintanat-ananworanich
64686664 the-hiv-aids-epidemic-in-asia-jintanat-ananworanichVeterans General Hospital, Taipei
 
Socio economic impact of hivaids & mental health (Syed Aljunid)
Socio economic impact of hivaids & mental health (Syed Aljunid)Socio economic impact of hivaids & mental health (Syed Aljunid)
Socio economic impact of hivaids & mental health (Syed Aljunid)Hidzuan Hashim
 
info4africa/MRC KZN Community Forum | 15 April 2014 | Adolescent HIV risk an...
info4africa/MRC KZN Community Forum | 15 April 2014 |  Adolescent HIV risk an...info4africa/MRC KZN Community Forum | 15 April 2014 |  Adolescent HIV risk an...
info4africa/MRC KZN Community Forum | 15 April 2014 | Adolescent HIV risk an...
info4africa
 
Hiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi SarkarHiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi Sarkar
mrikara185
 
Geographic Factors Affecting HIV/AIDS in South Africa (Prevention vs. Treatme...
Geographic Factors Affecting HIV/AIDS in South Africa (Prevention vs. Treatme...Geographic Factors Affecting HIV/AIDS in South Africa (Prevention vs. Treatme...
Geographic Factors Affecting HIV/AIDS in South Africa (Prevention vs. Treatme...Tom McLean
 
Gender,HIV/AIDs Transmission: Socio Economic And Socio Cultural Impact in Tan...
Gender,HIV/AIDs Transmission: Socio Economic And Socio Cultural Impact in Tan...Gender,HIV/AIDs Transmission: Socio Economic And Socio Cultural Impact in Tan...
Gender,HIV/AIDs Transmission: Socio Economic And Socio Cultural Impact in Tan...
Sandeep Singh
 
Integrated Disease Surveillance Project (IDSP)
Integrated Disease Surveillance Project (IDSP)Integrated Disease Surveillance Project (IDSP)
Integrated Disease Surveillance Project (IDSP)
Vivek Varat
 
descriptive epidemiology
descriptive epidemiologydescriptive epidemiology
descriptive epidemiologySagar Dalal
 
HIV AIDS & PREVENTION PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
HIV AIDS & PREVENTION  PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.comHIV AIDS & PREVENTION  PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
HIV AIDS & PREVENTION PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
Sarath Thomas
 
Concept of Adolescent Sexual & Reproductive Health (ASRH), Problems, Control ...
Concept of Adolescent Sexual & Reproductive Health (ASRH), Problems, Control ...Concept of Adolescent Sexual & Reproductive Health (ASRH), Problems, Control ...
Concept of Adolescent Sexual & Reproductive Health (ASRH), Problems, Control ...
Md Jahirul Islam Sojib
 
Public health surveillance
Public health surveillancePublic health surveillance
Public health surveillance
Dr Khyati Boriya -BDS (MHA)
 
HIV-AIDS-Prevention & Control
HIV-AIDS-Prevention & ControlHIV-AIDS-Prevention & Control
Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology
coolboy101pk
 
Surveillance
SurveillanceSurveillance
Surveillance
Akhilesh Bhargava
 
HIV Testing and Counselling (HTC)
HIV Testing and Counselling (HTC)HIV Testing and Counselling (HTC)
HIV Testing and Counselling (HTC)Dr Ajith Karawita
 

Viewers also liked (20)

HIV/AIDS Among Persons Aged 50 years and Older
HIV/AIDS Among Persons Aged 50 years and OlderHIV/AIDS Among Persons Aged 50 years and Older
HIV/AIDS Among Persons Aged 50 years and Older
 
Outline of the Philadelphia Prevention Plan
Outline of the Philadelphia Prevention PlanOutline of the Philadelphia Prevention Plan
Outline of the Philadelphia Prevention Plan
 
64686664 the-hiv-aids-epidemic-in-asia-jintanat-ananworanich
64686664 the-hiv-aids-epidemic-in-asia-jintanat-ananworanich64686664 the-hiv-aids-epidemic-in-asia-jintanat-ananworanich
64686664 the-hiv-aids-epidemic-in-asia-jintanat-ananworanich
 
Socio economic impact of hivaids & mental health (Syed Aljunid)
Socio economic impact of hivaids & mental health (Syed Aljunid)Socio economic impact of hivaids & mental health (Syed Aljunid)
Socio economic impact of hivaids & mental health (Syed Aljunid)
 
info4africa/MRC KZN Community Forum | 15 April 2014 | Adolescent HIV risk an...
info4africa/MRC KZN Community Forum | 15 April 2014 |  Adolescent HIV risk an...info4africa/MRC KZN Community Forum | 15 April 2014 |  Adolescent HIV risk an...
info4africa/MRC KZN Community Forum | 15 April 2014 | Adolescent HIV risk an...
 
Hiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi SarkarHiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi Sarkar
 
Hiv prevention
Hiv preventionHiv prevention
Hiv prevention
 
Geographic Factors Affecting HIV/AIDS in South Africa (Prevention vs. Treatme...
Geographic Factors Affecting HIV/AIDS in South Africa (Prevention vs. Treatme...Geographic Factors Affecting HIV/AIDS in South Africa (Prevention vs. Treatme...
Geographic Factors Affecting HIV/AIDS in South Africa (Prevention vs. Treatme...
 
Gender,HIV/AIDs Transmission: Socio Economic And Socio Cultural Impact in Tan...
Gender,HIV/AIDs Transmission: Socio Economic And Socio Cultural Impact in Tan...Gender,HIV/AIDs Transmission: Socio Economic And Socio Cultural Impact in Tan...
Gender,HIV/AIDs Transmission: Socio Economic And Socio Cultural Impact in Tan...
 
Integrated Disease Surveillance Project (IDSP)
Integrated Disease Surveillance Project (IDSP)Integrated Disease Surveillance Project (IDSP)
Integrated Disease Surveillance Project (IDSP)
 
descriptive epidemiology
descriptive epidemiologydescriptive epidemiology
descriptive epidemiology
 
HIV AIDS & PREVENTION PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
HIV AIDS & PREVENTION  PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.comHIV AIDS & PREVENTION  PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
HIV AIDS & PREVENTION PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
 
Concept of Adolescent Sexual & Reproductive Health (ASRH), Problems, Control ...
Concept of Adolescent Sexual & Reproductive Health (ASRH), Problems, Control ...Concept of Adolescent Sexual & Reproductive Health (ASRH), Problems, Control ...
Concept of Adolescent Sexual & Reproductive Health (ASRH), Problems, Control ...
 
Public health surveillance
Public health surveillancePublic health surveillance
Public health surveillance
 
HIV-AIDS-Prevention & Control
HIV-AIDS-Prevention & ControlHIV-AIDS-Prevention & Control
HIV-AIDS-Prevention & Control
 
Surveillance
SurveillanceSurveillance
Surveillance
 
Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology
 
Surveillance
SurveillanceSurveillance
Surveillance
 
Hiv aids in india
Hiv  aids in indiaHiv  aids in india
Hiv aids in india
 
HIV Testing and Counselling (HTC)
HIV Testing and Counselling (HTC)HIV Testing and Counselling (HTC)
HIV Testing and Counselling (HTC)
 

Similar to A basic understanding of HIV surveillance

HIV Epidemiology in the Prairies
HIV Epidemiology in the PrairiesHIV Epidemiology in the Prairies
HIV Epidemiology in the Prairies
griehl
 
Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024
Motahar Alam
 
Management of patient with AIDS
Management of patient with AIDSManagement of patient with AIDS
Management of patient with AIDS
Mathew Varghese V
 
HIV/AIDS | AS16
HIV/AIDS | AS16HIV/AIDS | AS16
HIV/AIDS | AS16
Aasik Shrestha
 
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptxHUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
JezzelGraceSalvadorB
 
HIV/AIDS
HIV/AIDS HIV/AIDS
Running head RESEARCH PAPER1RESEARCH PAPER.docx
Running head RESEARCH PAPER1RESEARCH PAPER.docxRunning head RESEARCH PAPER1RESEARCH PAPER.docx
Running head RESEARCH PAPER1RESEARCH PAPER.docx
todd521
 
Seminar on hiv
Seminar on hivSeminar on hiv
Seminar on hiv
Ramesh Jangid
 
32331.ppt
32331.ppt32331.ppt
32331.ppt
Rajveer71
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™
 
Key Facts over HIV by Dr. Milind Kulkarni
Key Facts over HIV by Dr. Milind KulkarniKey Facts over HIV by Dr. Milind Kulkarni
Key Facts over HIV by Dr. Milind Kulkarni
Parvez Pathan
 
One
OneOne
HIV/AIDS REPORT MT LAWS
HIV/AIDS REPORT MT LAWSHIV/AIDS REPORT MT LAWS
HIV/AIDS REPORT MT LAWSqncyamresss
 
HAP 752 Semester Long Project Write-Up Koyin Aladesuru Linkedin
HAP 752 Semester Long Project Write-Up Koyin Aladesuru LinkedinHAP 752 Semester Long Project Write-Up Koyin Aladesuru Linkedin
HAP 752 Semester Long Project Write-Up Koyin Aladesuru LinkedinKoyin Aladesuru
 
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
e632 www.thelancet.comhiv   Vol 6   September 2019Viewpoie632 www.thelancet.comhiv   Vol 6   September 2019Viewpoi
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
AlyciaGold776
 
Hiv Essay
Hiv EssayHiv Essay
Hiv Essay
Emily Jones
 
HIV-AIDS
HIV-AIDSHIV-AIDS
Mathematical modeling
Mathematical modelingMathematical modeling
Mathematical modeling
miguelhowella
 
Presentation on HIV-AIDS - Copy.pptx
Presentation on HIV-AIDS - Copy.pptxPresentation on HIV-AIDS - Copy.pptx
Presentation on HIV-AIDS - Copy.pptx
Rebecca56466
 
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working? Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
CrimsonPublishers-PRM
 

Similar to A basic understanding of HIV surveillance (20)

HIV Epidemiology in the Prairies
HIV Epidemiology in the PrairiesHIV Epidemiology in the Prairies
HIV Epidemiology in the Prairies
 
Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024
 
Management of patient with AIDS
Management of patient with AIDSManagement of patient with AIDS
Management of patient with AIDS
 
HIV/AIDS | AS16
HIV/AIDS | AS16HIV/AIDS | AS16
HIV/AIDS | AS16
 
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptxHUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
 
HIV/AIDS
HIV/AIDS HIV/AIDS
HIV/AIDS
 
Running head RESEARCH PAPER1RESEARCH PAPER.docx
Running head RESEARCH PAPER1RESEARCH PAPER.docxRunning head RESEARCH PAPER1RESEARCH PAPER.docx
Running head RESEARCH PAPER1RESEARCH PAPER.docx
 
Seminar on hiv
Seminar on hivSeminar on hiv
Seminar on hiv
 
32331.ppt
32331.ppt32331.ppt
32331.ppt
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
 
Key Facts over HIV by Dr. Milind Kulkarni
Key Facts over HIV by Dr. Milind KulkarniKey Facts over HIV by Dr. Milind Kulkarni
Key Facts over HIV by Dr. Milind Kulkarni
 
One
OneOne
One
 
HIV/AIDS REPORT MT LAWS
HIV/AIDS REPORT MT LAWSHIV/AIDS REPORT MT LAWS
HIV/AIDS REPORT MT LAWS
 
HAP 752 Semester Long Project Write-Up Koyin Aladesuru Linkedin
HAP 752 Semester Long Project Write-Up Koyin Aladesuru LinkedinHAP 752 Semester Long Project Write-Up Koyin Aladesuru Linkedin
HAP 752 Semester Long Project Write-Up Koyin Aladesuru Linkedin
 
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
e632 www.thelancet.comhiv   Vol 6   September 2019Viewpoie632 www.thelancet.comhiv   Vol 6   September 2019Viewpoi
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
 
Hiv Essay
Hiv EssayHiv Essay
Hiv Essay
 
HIV-AIDS
HIV-AIDSHIV-AIDS
HIV-AIDS
 
Mathematical modeling
Mathematical modelingMathematical modeling
Mathematical modeling
 
Presentation on HIV-AIDS - Copy.pptx
Presentation on HIV-AIDS - Copy.pptxPresentation on HIV-AIDS - Copy.pptx
Presentation on HIV-AIDS - Copy.pptx
 
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working? Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
 

More from Dr.RAJEEV KASHYAP

Smoke free policies- evaluating the effectiveness
Smoke free policies-  evaluating the effectivenessSmoke free policies-  evaluating the effectiveness
Smoke free policies- evaluating the effectiveness
Dr.RAJEEV KASHYAP
 
Commercial private health sector
Commercial private health sectorCommercial private health sector
Commercial private health sector
Dr.RAJEEV KASHYAP
 
Standard operating procedure for CTA
Standard operating procedure for CTAStandard operating procedure for CTA
Standard operating procedure for CTADr.RAJEEV KASHYAP
 
Smoke free policies- evaluating the effectiveness
Smoke free policies-  evaluating the effectivenessSmoke free policies-  evaluating the effectiveness
Smoke free policies- evaluating the effectivenessDr.RAJEEV KASHYAP
 
C TA - standard operating procedures
C TA - standard operating proceduresC TA - standard operating procedures
C TA - standard operating procedures
Dr.RAJEEV KASHYAP
 
Pathway to changing and improving health care
Pathway to changing and improving health carePathway to changing and improving health care
Pathway to changing and improving health care
Dr.RAJEEV KASHYAP
 
Monitoring and evaluation (2)
Monitoring and evaluation (2)Monitoring and evaluation (2)
Monitoring and evaluation (2)Dr.RAJEEV KASHYAP
 
A basic understanding o f H I V surveillance
A basic understanding o f H I V surveillanceA basic understanding o f H I V surveillance
A basic understanding o f H I V surveillanceDr.RAJEEV KASHYAP
 
Tobacco and oral cancer cancer
Tobacco and oral cancer  cancerTobacco and oral cancer  cancer
Tobacco and oral cancer cancerDr.RAJEEV KASHYAP
 
Personal information protection and electronic documents act
Personal information protection and electronic documents actPersonal information protection and electronic documents act
Personal information protection and electronic documents actDr.RAJEEV KASHYAP
 
Natural Health Products Regulations (2)
Natural Health Products Regulations (2)Natural Health Products Regulations (2)
Natural Health Products Regulations (2)Dr.RAJEEV KASHYAP
 
Natural Health Products Regulations
Natural Health Products RegulationsNatural Health Products Regulations
Natural Health Products RegulationsDr.RAJEEV KASHYAP
 
The Electronic Regulatory Submission
The Electronic Regulatory SubmissionThe Electronic Regulatory Submission
The Electronic Regulatory SubmissionDr.RAJEEV KASHYAP
 
Atenolol Presentation Clin 210 50
Atenolol   Presentation Clin 210 50Atenolol   Presentation Clin 210 50
Atenolol Presentation Clin 210 50Dr.RAJEEV KASHYAP
 

More from Dr.RAJEEV KASHYAP (20)

Smoke free policies- evaluating the effectiveness
Smoke free policies-  evaluating the effectivenessSmoke free policies-  evaluating the effectiveness
Smoke free policies- evaluating the effectiveness
 
Commercial private health sector
Commercial private health sectorCommercial private health sector
Commercial private health sector
 
Standard operating procedure for CTA
Standard operating procedure for CTAStandard operating procedure for CTA
Standard operating procedure for CTA
 
Smoke free policies- evaluating the effectiveness
Smoke free policies-  evaluating the effectivenessSmoke free policies-  evaluating the effectiveness
Smoke free policies- evaluating the effectiveness
 
C TA - standard operating procedures
C TA - standard operating proceduresC TA - standard operating procedures
C TA - standard operating procedures
 
Pathway to changing and improving health care
Pathway to changing and improving health carePathway to changing and improving health care
Pathway to changing and improving health care
 
Cancer epidemiology
Cancer epidemiologyCancer epidemiology
Cancer epidemiology
 
Monitoring and evaluation (2)
Monitoring and evaluation (2)Monitoring and evaluation (2)
Monitoring and evaluation (2)
 
Health research methodology
Health research methodologyHealth research methodology
Health research methodology
 
A basic understanding o f H I V surveillance
A basic understanding o f H I V surveillanceA basic understanding o f H I V surveillance
A basic understanding o f H I V surveillance
 
Tobacco and oral cancer cancer
Tobacco and oral cancer  cancerTobacco and oral cancer  cancer
Tobacco and oral cancer cancer
 
Personal information protection and electronic documents act
Personal information protection and electronic documents actPersonal information protection and electronic documents act
Personal information protection and electronic documents act
 
Natural Health Products Regulations (2)
Natural Health Products Regulations (2)Natural Health Products Regulations (2)
Natural Health Products Regulations (2)
 
Natural Health Products Regulations
Natural Health Products RegulationsNatural Health Products Regulations
Natural Health Products Regulations
 
Acupressure
AcupressureAcupressure
Acupressure
 
The Electronic Regulatory Submission
The Electronic Regulatory SubmissionThe Electronic Regulatory Submission
The Electronic Regulatory Submission
 
Smile Counts Dental Care
Smile Counts   Dental CareSmile Counts   Dental Care
Smile Counts Dental Care
 
Multiple Sclerosis
Multiple SclerosisMultiple Sclerosis
Multiple Sclerosis
 
Waste Management
Waste ManagementWaste Management
Waste Management
 
Atenolol Presentation Clin 210 50
Atenolol   Presentation Clin 210 50Atenolol   Presentation Clin 210 50
Atenolol Presentation Clin 210 50
 

Recently uploaded

Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 

Recently uploaded (20)

Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 

A basic understanding of HIV surveillance

  • 1. A Basic Understanding of HIV SurveillanceReferenceSOURCEUNAIDS/WHO Dr Rajeev Kashyap B.Sc., B.D.S ., M.Sc. (DPH)U.K C.C.R.A., P.M.I., C.R.A.A(Canada)
  • 2. Impact of the HIV/AIDS worldwide epidemic Every day, over 6,800 persons become infected with HIV. Every day, over 5,700 persons die from AIDS, mostly because of lack of access to HIV prevention and treatment services. (Source: UNAIDS/WHO 2007)
  • 3. Prevalence of the Epidemic
  • 4.
  • 5. Macrophages As the number of these cells is depleted because of the virus, patients become immunodeficient, meaning their immune systems are insufficient to ward off infections. They develop opportunistic infections and certain cancers.
  • 7. How HIV Is Transmitted Both HIV-1 and HIV-2 are transmitted in the same ways: The predominant route of transmission is through Unprotected heterosexual intercourse or Homosexual intercourse between men. HIV is also transmitted through blood, blood products, and donated organs (also referred to as parenteral transmission).  HIV may be transmitted from an infected mother to her fetus or infant during pregnancy, delivery or when breastfeeding (also referred to as perinatal transmission).
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. Factors that Affect HIV/AIDS Prevalence High prevalence of sexually transmitted infections (STIs)  Limited access to STI management Limited access to, or social non-acceptance of, condoms War and civil disturbance Cultural/ethnic practices Women’s low status Low literacy rates Increasing urbanization, migration, and mobilization Low level of political commitment Exposure to blood from unsafe medical practices and/or traditional practices
  • 13. The two main factors driving the HIV/AIDS epidemic in Asia are injection drug use and commercial sex.
  • 14.
  • 15. Prevention of Mother-To-Child Transmission A short-course antiretroviral regimen given to the mother and the newborn baby can substantially reduce the risk of perinatal transmission of HIV during pregnancy and childbirth.
  • 16. HIV-Positive Mothers HIV-positive mothers can avoid the risk of transmission through infected breast milk by using breast milk substitutes. However, significant health risks are associated with this practice: Malnutrition Exposure to other infections For this reason, WHO/UNICEF/UNAIDS have developed several documents that address HIV and breastfeeding.
  • 18. Antiretroviral drugs are used to treat HIV infection. In the past, the high cost of these drugs made them rarely used in most developing countries. Several agencies are now making funds available for antiretroviral and other therapies. These organizations includeThe Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Bank Multi-sectoral AIDS Plan (MAP) and The United States President’s Emergency Plan for AIDS Relief (PEPFAR).
  • 19. ARV Therapy ARV therapy has reduced the rate of progressing to AIDS in areas where these drugs are accessible. It has also been associated with changes in the types of opportunistic infections that appear with AIDS.
  • 20. Classes of antiretroviral drugs There are three classes of antiretroviral drugs: Nucleoside reverse transcriptase inhibitors (NRTIs) Non-nucleoside reverse transcriptase inhibitors (nNRTIs) Protease inhibitors (Pis)
  • 21. WHO recommends the following antiretroviral therapy strategy First line drugs: 2 NRTI + 1 NNRTI Second line drugs: 2 NRTI + PI  Surveillance is an important tool to monitor drug resistance in populations on treatment.
  • 22. Preventing & Treating Opportunistic Infections In addition to antiretroviral drugs, the treatment of HIV infection includes diagnosis, prophylaxis, andtreatment of selected opportunistic infections. Anti-tuberculosis (TB) drugs extend the lives of patients with both HIV and TB. Cotrimoxazoleprophylaxis has been used successfully to prevent the onset of opportunistic infections in HIV-positive patients in sub-Saharan Africa. Vaccines are available for some potential opportunistic infections, such as pneumococcal disease
  • 23. Main Components of Public Health Surveillance The main components of surveillance include: The systematic collection, analysis, and evaluation of morbidity and mortality reports and other relevant data Timely and regular distribution of information about the trends and patterns of disease to those who need to know Use of the information for disease prevention and control measures  An important part of the definition is that surveillance systems involve ongoing collection and use of health data
  • 24. SomeProblems -disease surveillance systems Duplication of effort Delay in reporting Inadequate data collection, analysis, use and dissemination Lack of integrated training Lack of evaluation Lack of laboratory involvement and coordination Lack of supervision
  • 25.
  • 27.
  • 34.
  • 35. Relationship between Disease and Case Definition
  • 36. Relationship between disease and case definition is described in definitions below Sensitivity - The ability of a case definition or laboratory test to predict true disease (a/(a+c)). Specificity - The ability of a case definition or laboratory test to predict absence of true disease (d/(b+d)). Positive predictive value - The proportion of persons meeting a case definition, having a positive laboratory test that have true disease (a/(a+b)). Negative predictive value - The proportion of persons not meeting a case definition, having a negative laboratory test that do not have true disease (d/(c+d)).
  • 37. Purpose of HIV/AIDS Surveillance Epidemiologic surveillance is to detect trends in disease incidence and prevalenceover time Providing an accurate assessment of the distribution of disease by person, place and time Providing information on changes or trends in disease distribution by geographic, socio-demographic or exposure parameters Identifying groups or geographical areas for targeted intervention efforts Providing information to evaluate effectiveness of intervention efforts Providing data for prevention program management (such as for voluntary counselling and testing, prevention of mother-to-child transmission and sexually transmitted infection management) Providing data for development and implementation of research efforts
  • 38. Prevalence and Incidence Prevalence measures the level of HIV infection in a population. It is measured as a unitless proportion, such as the percent infected or the number of infections per thousand persons tested. Prevalence is influenced by both the rate of new infections (incidence) and the rate that infected people leave the population by death, cure or migration. Incidence is the rate at which new HIV infections occur in a population in a given period of time. Because it is a rate, its unit of measurement always has time in the denominator
  • 39. Core Elements HIV case reporting involves routinely reporting all cases of HIV infection to accurately monitor the HIV epidemic, assess how the epidemic is changing, and create programs for HIV prevention and medical care that best serve affected people and communities. AIDS case reporting involves routine reporting of specific data elements for persons diagnosed with AIDS in all or selected health facilities in the country to monitor AIDS morbidity in the general population. HIV sero-surveillance seeks to estimate the prevalence of HIV infection in selected populations such as antenatal clinic (ANC) attendees, STI patients and blood donors by conducting sero-prevalence surveys in these populations on an ongoing basis.
  • 41. Summary( Recap) The purpose of HIV/AIDS surveillance is to provide an accurate picture of the epidemic, which will then help to guide prevention and treatment programs. It helps to identify population sub-groups that are at higher risk for infection. Also, more information is provided on the distribution of disease over time and space. Now think of what the situation is like in your country. What is the approximate HIV prevalence in your district or province? Which sub-populations are most affected by the HIV/AIDS epidemic in your region?
  • 42. The HIV/AIDS epidemic is becoming larger and more complex. Surveillance efforts must become more sophisticated if they are to be effective.
  • 43. Today, we use second-generation HIV surveillance, which is designed to collect and integrate data reported from a variety of other sources:Behavioural surveillanceHIV/AIDS case reportingDeath registrationSexually transmitted infection (STI) surveillanceAdditional data provide a more comprehensive understanding of trends in the epidemic as well as the effectiveness of control and prevention measures.
  • 44.
  • 45. Today, we use second-generation HIV surveillance, which is designed to collect and integrate data reported from a variety of other sources:Behavioural surveillanceHIV/AIDS case reportingDeath registrationSexually transmitted infection (STI) surveillanceAdditional data provide a more comprehensive understanding of trends in the epidemic as well as the effectiveness of control and prevention measures.
  • 46. Goals The goals of second-generation HIV surveillance are: Better understanding of trends over time Better understanding of the behaviours driving the epidemic in a country Increased focus on sub-populations at highest risk for infection Flexibility to change with the state of the epidemic
  • 47.
  • 48.
  • 49.
  • 51.
  • 52. Concentrated Epidemic Characteristics of a concentrated epidemic include: HIV has spread rapidly in a defined sub-population, but is not well-established in the general population. HIV prevalence is consistently over 5% in at least one defined sub-population. HIV prevalence is below 1% in pregnant women in urban areas. This epidemic state suggests active networks of risk within the sub-population.
  • 53. Generalized Epidemic Characteristics of a generalized epidemic include: HIV is firmly established in the general population. HIV prevalence consistently over 1% in pregnant women. Sexual networking in the general population is sufficient to sustain an epidemic independent of sub-populations at higher risk for infection.
  • 54. Summary( Recap) The three epidemic classifications explain the extent of the impact and transmission of the HIV/AIDS epidemic. Each relates to specific characteristics of the epidemic. The three types are listed below: Low-Level Concentrated Generalized